HPV Molecular Diagnostics Boosting Global Infectious Testing Revenue Patterns

Press Release   •   Jul 30, 2012 15:18 IST

A new research report from RNCOS reveals that the molecular diagnostics (MDx) market has emerged as one of the fastest growing segments of global IVD industry. In 2011, the overall market is estimated to have reached around US$ 5.4 Billion, globally and is further predicted to grow at a healthy double-digit CAGR during 2012-2015. This growth is primarily to be driven by factors like technology advancements, new innovations resulting in faster & more accurate diagnosis and increasing awareness level amongst consumers.

The infectious diseases molecular diagnostics market remains the largest revenue contributor in the MDx market. Within this segment, MDx tests market for Human Papillomavirus (HPV) is growing rapidly and is expected to grow at a CAGR of around 14% during 2012-2015.  This is mainly due to the growing evidence from research studies that links HPV with cancer. Besides cervical cancer, HPV has now also been shown to be a causative agent in various anogenital cancers (anus, vulva, vagina and penis) and head and neck cancers.

The report, “Infectious Disease Molecular Diagnostics Outlook 2015”, provides an effective insight and prudent analysis of the current status and future positioning of the global infectious diseases’ MDx market. It projects the future size of overall market for 2012-2015 and covers effective description of key drivers and trends that will propel the growth.

Moreover, the report illustrates the current performance of key infectious disease diagnostic segments (in terms of indications) to enumerate vertical sector demand. It analyzes the opportunity assessment for companies in the market in terms of technologies (e.g. PCR, RT-PCR, NASBA etc.) and disease prevalence. Additionally, an in-depth insight into the FDA approved diagnostics products along with recent industry developments has been included in the report to provide a balanced outlook on the potentials of the global infectious diseases MDx sector.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM411.htm

Some of our Related Reports are:

- Global API Market Analysis (http://www.rncos.com/Report/IM424.htm)
- Global Telemedicine Market Analysis (http://www.rncos.com/Report/IM331.htm)
- Personalized Medicine Market Analysis (http://www.rncos.com/Report/IM305.htm)
- Global Regenerative Medicine Market (http://www.rncos.com/Report/IM363.htm)
- Emerging Pharmaceutical Markets Globally(http://www.rncos.com/Report/IM081.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm


RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.